Form 4: Keurig Dr Pepper Executive Karin Rotem-Wildeman Acquires 24,055 Restricted Stock Units

Chief R&D Officer of Keurig Dr Pepper, Karin Rotem-Wildeman, reports the acquisition of 24,055 restricted stock units (RSUs) on March 4, 2024, subject to vesting conditions.

Summary

• Karin Rotem-Wildeman, Chief R&D Officer of Keurig Dr Pepper Inc., acquired 24,055 restricted stock units on March 4, 2024.
• These RSUs are subject to vesting conditions, with 60% vesting on March 4, 2027, 20% on March 4, 2028, and the remaining 20% on March 4, 2029.
• Each RSU represents a contingent right to receive one share of Keurig Dr Pepper's common stock upon vesting.
• The transaction was reported on a Form 4 filing with the SEC.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices and aligns executive interests with shareholder value. The vesting schedule indicates a long-term commitment.

Positives

• The acquisition of RSUs by a key executive signals confidence in the company's future performance.

Future Outlook

The vesting schedule indicates a long-term commitment by the executive to the company's success.

Industry Context

Executive compensation in the form of stock options and restricted stock units is a common practice in publicly traded companies to align management's interests with those of shareholders.

Comparison to Industry Standards

• Granting restricted stock units is a typical compensation strategy for retaining and incentivizing key executives in the beverage industry.
• Companies like Coca-Cola and PepsiCo also utilize similar equity-based compensation plans for their executives.

Stakeholder Impact

• The RSU grant aligns the executive's interests with those of shareholders, potentially driving long-term value creation.

Key Dates